Opportunity ID: 274995
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-CE15-1501 |
Funding Opportunity Title: | Prescription Drug Overdose Prevention for States |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 16 |
Assistance Listings: | 93.136 — Injury Prevention and Control Research and State and Community Based Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 18 |
Posted Date: | Mar 06, 2015 |
Last Updated Date: | May 27, 2015 |
Original Closing Date for Applications: | May 08, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
Current Closing Date for Applications: | Jun 02, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
Archive Date: | Jul 02, 2015 |
Estimated Total Program Funding: | $55,600,000 |
Award Ceiling: | $1,000,000 |
Award Floor: | $750,000 |
Eligibility
Eligible Applicants: | State governments |
Additional Information on Eligibility: | Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost. Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding. Applicants must provide a Letter of Support (LOS) from: A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities. Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities. |
Additional Information
Agency Name: | Centers for Disease Control and Prevention |
Description: | The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem. |
Link to Additional Information: | |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Eric Gross
EUW9@cdc.gov Email:EUW9@cdc.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. | May 27, 2015 | |
Jun 18, 2016 | ||
Jun 18, 2016 | ||
Jun 18, 2016 | ||
May 27, 2015 | ||
May 27, 2015 | ||
The purpose of Admendment 2 is to change the due date to June 2, 2015 | May 27, 2015 | |
The purpose of Amendment 1 to this FOA is to provide additional clarifying information based on questions received from potential applicants during the Pre-Application Informational Conference Call held on March 11, 2015. A summary of the questions and answers can be found in Section H. Other Information beginning on page 39 of the amended FOA. |
May 27, 2015 | |
The purpose of Amendment 1 to this FOA is to provide additional clarifying information based on questions received from potential applicants during the Pre-Application Informational Conference Call held on March 11, 2015. A summary of the questions and answers can be found in Section H. Other Information beginning on page 39 of the amended FOA. |
Mar 27, 2015 | |
Mar 27, 2015 | ||
Mar 27, 2015 | ||
Mar 27, 2015 | ||
Mar 27, 2015 | ||
Mar 27, 2015 | ||
Mar 27, 2015 | ||
Mar 27, 2015 | ||
Mar 27, 2015 | ||
Mar 27, 2015 | ||
The correct closing date for this FOA is May 8, 2015, please retrieve a new application package from Grants.gov with the correct closing date. LCB |
Mar 27, 2015 | |
The correct closing date for this FOA is May 8, 2015, please retrieve a new application package from Grants.gov with the correct closing date. LCB |
Mar 13, 2015 | |
Mar 13, 2015 |
DISPLAYING: Synopsis 18
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-CE15-1501 |
Funding Opportunity Title: | Prescription Drug Overdose Prevention for States |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 16 |
Assistance Listings: | 93.136 — Injury Prevention and Control Research and State and Community Based Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 18 |
Posted Date: | Mar 06, 2015 |
Last Updated Date: | May 27, 2015 |
Original Closing Date for Applications: | May 08, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
Current Closing Date for Applications: | Jun 02, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
Archive Date: | Jul 02, 2015 |
Estimated Total Program Funding: | $55,600,000 |
Award Ceiling: | $1,000,000 |
Award Floor: | $750,000 |
Eligibility
Eligible Applicants: | State governments |
Additional Information on Eligibility: | Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost. Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding. Applicants must provide a Letter of Support (LOS) from: A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities. Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities. |
Additional Information
Agency Name: | Centers for Disease Control and Prevention |
Description: | The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem. |
Link to Additional Information: | |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Eric Gross
EUW9@cdc.gov Email:EUW9@cdc.gov |
DISPLAYING: Forecast 3
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-CE15-1501 |
Funding Opportunity Title: | Prescription Drug Overdose Prevention for States |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 16 |
Assistance Listings: | 93.136 — Injury Prevention and Control Research and State and Community Based Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Forecast 3 |
Posted Date: | Jun 18, 2016 |
Last Updated Date: | Jun 18, 2016 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | – |
Archive Date: | May 30, 2015 |
Estimated Total Program Funding: | $55,600,000 |
Award Ceiling: | $1,000,000 |
Award Floor: | $750,000 |
Eligibility
Eligible Applicants: | State governments |
Additional Information on Eligibility: | Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost. Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding. Applicants must provide a Letter of Support (LOS) from: A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities. The state substance abuse services authority in their state. The LOS must show that the substance abuse authority supports the application and agrees to regular meetings to support and coordinate activities. The PDMP authority in their state showing the PDMP authority supports the application, agrees to quarterly meetings to support and coordinate activities, and how the PDMP authority will facilitate proposed activities for enhancing and maximizing the state’s PDMP. Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities. If the priority strategy of policy evaluation is chosen, applicants must provide a LOS from agencies that maintain access to relevant data the awardee will be using for evaluation. The LOS must indicate the agency’s support and agreement to share data with the awardee for evaluation purposes. |
Additional Information
Agency Name: | – |
Description: | The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
–
Email:EUW9@cdc.gov |
DISPLAYING: Forecast 2
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-CE15-1501 |
Funding Opportunity Title: | Prescription Drug Overdose Prevention for States |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 16 |
Assistance Listings: | 93.136 — Injury Prevention and Control Research and State and Community Based Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Forecast 2 |
Posted Date: | Jun 18, 2016 |
Last Updated Date: | Jun 18, 2016 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | – |
Archive Date: | May 30, 2015 |
Estimated Total Program Funding: | $55,600,000 |
Award Ceiling: | $1,000,000 |
Award Floor: | $750,000 |
Eligibility
Eligible Applicants: | State governments |
Additional Information on Eligibility: | Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Boost states that do not apply or are not awarded funds under this program will continue their work under Boost. Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding. The award floor is $750,000 and the award ceiling is $1,000,000 for this FOA. CDC will consider any application that is beyond or below these parameters as non-responsive and it will receive no further review. Applicants must provide a LOS from a state-level law enforcement authority in their state. The LOS must show that the authority supports the application and agrees to regular meetings to support and coordinate activities. Applicants must provide a LOS from the PDMP authority in their state showing the authority supports the application, agrees to quarterly meetings to support and coordinate activities, and how the authority will facilitate proposed activities for enhancing and maximizing the state’s PDMP Applicants must provide a LOS from the state authority managing the entity where the work under the “implement insurer and health systems” priority strategy is focused. For example, if a proposal is for creating an opioid management program for the Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from that authority. If the applicant is integrating and/or disseminating CDC Opioid Prescribing Guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the authority will facilitate the proposed activities. If the priority strategy of policy evaluation is chosen, applicants must provide a LOS from agencies that maintain access to relevant data the state be using for evaluation. For example, provide a LOS from law enforcement agencies or medical boards if their data is to be used in evaluation. The LOS must indicate the agency’s support and agreement to share data with the awardee for evaluation purposes. |
Additional Information
Agency Name: | – |
Description: | The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
–
Email:EUW9@cdc.gov |
DISPLAYING: Forecast 1
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-CE15-1501 |
Funding Opportunity Title: | Prescription Drug Overdose Prevention for States |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 16 |
Assistance Listings: | 93.136 — Injury Prevention and Control Research and State and Community Based Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Forecast 1 |
Posted Date: | Jun 18, 2016 |
Last Updated Date: | Jun 18, 2016 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | – |
Archive Date: | Jun 04, 2015 |
Estimated Total Program Funding: | $55,600,000 |
Award Ceiling: | $1,000,000 |
Award Floor: | $750,000 |
Eligibility
Eligible Applicants: | State governments |
Additional Information on Eligibility: | Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Boost states that do not apply or are not awarded funds under this program will continue their work under Boost. Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding. The award floor is $750,000 and the award ceiling is $1,000,000 for this FOA. CDC will consider any application that is beyond or below these parameters as non-responsive and it will receive no further review. Applicants must provide a LOS from a state-level law enforcement authority in their state. The LOS must show that the authority supports the application and agrees to regular meetings to support and coordinate activities. Applicants must provide a LOS from the PDMP authority in their state showing the authority supports the application, agrees to quarterly meetings to support and coordinate activities, and how the authority will facilitate proposed activities for enhancing and maximizing the state’s PDMP Applicants must provide a LOS from the state authority managing the entity where the work under the “implement insurer and health systems” priority strategy is focused. For example, if a proposal is for creating an opioid management program for the Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from that authority. If the applicant is integrating and/or disseminating CDC Opioid Prescribing Guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the authority will facilitate the proposed activities. If the priority strategy of policy evaluation is chosen, applicants must provide a LOS from agencies that maintain access to the data being used for evaluation. The LOS must indicate the agency’s support and agreement to share data with the awardee for evaluation purposes. |
Additional Information
Agency Name: | – |
Description: | The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
–
Email:EUW9@cdc.gov |
DISPLAYING: Synopsis 17
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-CE15-1501 |
Funding Opportunity Title: | Prescription Drug Overdose Prevention for States |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 16 |
Assistance Listings: | 93.136 — Injury Prevention and Control Research and State and Community Based Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 17 |
Posted Date: | May 27, 2015 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Jun 02, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
Archive Date: | Jul 02, 2015 |
Estimated Total Program Funding: | $55,600,000 |
Award Ceiling: | $1,000,000 |
Award Floor: | $750,000 |
Eligibility
Eligible Applicants: | State governments |
Additional Information on Eligibility: | Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost. Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding. Applicants must provide a Letter of Support (LOS) from: A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities. Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities. |
Additional Information
Agency Name: | Centers for Disease Control and Prevention |
Description: | The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem. |
Link to Additional Information: | |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Eric Gross
EUW9@cdc.gov Email:EUW9@cdc.gov |
DISPLAYING: Synopsis 16
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-CE15-1501 |
Funding Opportunity Title: | Prescription Drug Overdose Prevention for States |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 16 |
Assistance Listings: | 93.136 — Injury Prevention and Control Research and State and Community Based Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 16 |
Posted Date: | May 27, 2015 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Jun 02, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
Archive Date: | Jul 02, 2015 |
Estimated Total Program Funding: | $55,600,000 |
Award Ceiling: | $1,000,000 |
Award Floor: | $750,000 |
Eligibility
Eligible Applicants: | State governments |
Additional Information on Eligibility: | Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost. Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding. Applicants must provide a Letter of Support (LOS) from: A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities. Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities. |
Additional Information
Agency Name: | Centers for Disease Control and Prevention |
Description: | The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem. |
Link to Additional Information: | |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Eric Gross
EUW9@cdc.gov Email:EUW9@cdc.gov |
DISPLAYING: Synopsis 15
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-CE15-1501 |
Funding Opportunity Title: | Prescription Drug Overdose Prevention for States |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 16 |
Assistance Listings: | 93.136 — Injury Prevention and Control Research and State and Community Based Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 15 |
Posted Date: | May 27, 2015 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Jun 02, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
Archive Date: | Jun 07, 2015 |
Estimated Total Program Funding: | $55,600,000 |
Award Ceiling: | $1,000,000 |
Award Floor: | $750,000 |
Eligibility
Eligible Applicants: | State governments |
Additional Information on Eligibility: | Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost.Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding.Applicants must provide a Letter of Support (LOS) from:A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities.The state substance abuse services authority in their state. The LOS must show that the substance abuse authority supports the application and agrees to regular meetings to support and coordinate activities.The PDMP authority in their state showing the PDMP authority supports the application, agrees to quarterly meetings to support and coordinate activities, and how the PDMP authority will facilitate proposed activities for enhancing and maximizing the state’s PDMP.Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities.If the priority strategy of policy evaluation is chosen, applicants must provide a LOS from agencies that maintain access to relevant data the state will be using for evaluation. The LOS must indicate the agency’s support and agreement to share data for evaluation purposes. |
Additional Information
Agency Name: | Centers for Disease Control and Prevention |
Description: | The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem. |
Link to Additional Information: | |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDC/PGO’
770-488-2700 Email:pgotim@cdc.gov |
DISPLAYING: Synopsis 14
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-CE15-1501 |
Funding Opportunity Title: | Prescription Drug Overdose Prevention for States |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 16 |
Assistance Listings: | 93.136 — Injury Prevention and Control Research and State and Community Based Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 14 |
Posted Date: | May 27, 2015 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | May 08, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
Archive Date: | Jun 07, 2015 |
Estimated Total Program Funding: | $55,600,000 |
Award Ceiling: | $1,000,000 |
Award Floor: | $750,000 |
Eligibility
Eligible Applicants: | State governments |
Additional Information on Eligibility: | Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost.Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding.Applicants must provide a Letter of Support (LOS) from:A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities.The state substance abuse services authority in their state. The LOS must show that the substance abuse authority supports the application and agrees to regular meetings to support and coordinate activities.The PDMP authority in their state showing the PDMP authority supports the application, agrees to quarterly meetings to support and coordinate activities, and how the PDMP authority will facilitate proposed activities for enhancing and maximizing the state’s PDMP.Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities.If the priority strategy of policy evaluation is chosen, applicants must provide a LOS from agencies that maintain access to relevant data the state will be using for evaluation. The LOS must indicate the agency’s support and agreement to share data for evaluation purposes. |
Additional Information
Agency Name: | Centers for Disease Control and Prevention |
Description: | The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem. |
Link to Additional Information: | |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Eric Gross
EUW9@cdc.gov Email:EUW9@cdc.gov |
DISPLAYING: Synopsis 13
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-CE15-1501 |
Funding Opportunity Title: | Prescription Drug Overdose Prevention for States |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 16 |
Assistance Listings: | 93.136 — Injury Prevention and Control Research and State and Community Based Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 13 |
Posted Date: | Mar 27, 2015 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | May 08, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
Archive Date: | Jun 07, 2015 |
Estimated Total Program Funding: | $55,600,000 |
Award Ceiling: | $1,000,000 |
Award Floor: | $750,000 |
Eligibility
Eligible Applicants: | State governments |
Additional Information on Eligibility: | Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost. Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding. Applicants must provide a Letter of Support (LOS) from: A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities. Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities. |
Additional Information
Agency Name: | Centers for Disease Control and Prevention |
Description: | The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem. |
Link to Additional Information: | |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Eric Gross
EUW9@cdc.gov Email:EUW9@cdc.gov |
DISPLAYING: Synopsis 12
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-CE15-1501 |
Funding Opportunity Title: | Prescription Drug Overdose Prevention for States |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 16 |
Assistance Listings: | 93.136 — Injury Prevention and Control Research and State and Community Based Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 12 |
Posted Date: | Mar 27, 2015 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | May 08, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
Archive Date: | Jun 07, 2015 |
Estimated Total Program Funding: | $55,600,000 |
Award Ceiling: | $1,000,000 |
Award Floor: | $750,000 |
Eligibility
Eligible Applicants: | State governments |
Additional Information on Eligibility: | Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost. Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding. Applicants must provide a Letter of Support (LOS) from: A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities. Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities. |
Additional Information
Agency Name: | Centers for Disease Control and Prevention |
Description: | The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem. |
Link to Additional Information: | |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Eric Gross
EUW9@cdc.gov Email:EUW9@cdc.gov |
DISPLAYING: Synopsis 11
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-CE15-1501 |
Funding Opportunity Title: | Prescription Drug Overdose Prevention for States |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 16 |
Assistance Listings: | 93.136 — Injury Prevention and Control Research and State and Community Based Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 11 |
Posted Date: | Mar 27, 2015 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | May 08, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
Archive Date: | Jun 07, 2015 |
Estimated Total Program Funding: | $55,600,000 |
Award Ceiling: | $1,000,000 |
Award Floor: | $750,000 |
Eligibility
Eligible Applicants: | State governments |
Additional Information on Eligibility: | Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost. Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding. Applicants must provide a Letter of Support (LOS) from: A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities. Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities. |
Additional Information
Agency Name: | Centers for Disease Control and Prevention |
Description: | The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem. |
Link to Additional Information: | |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Eric Gross
EUW9@cdc.gov Email:EUW9@cdc.gov |
DISPLAYING: Synopsis 10
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-CE15-1501 |
Funding Opportunity Title: | Prescription Drug Overdose Prevention for States |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 16 |
Assistance Listings: | 93.136 — Injury Prevention and Control Research and State and Community Based Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 10 |
Posted Date: | Mar 27, 2015 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | May 08, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
Archive Date: | Jun 07, 2015 |
Estimated Total Program Funding: | $55,600,000 |
Award Ceiling: | $1,000,000 |
Award Floor: | $750,000 |
Eligibility
Eligible Applicants: | State governments |
Additional Information on Eligibility: | Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost. Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding. Applicants must provide a Letter of Support (LOS) from: A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities. Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities. |
Additional Information
Agency Name: | Centers for Disease Control and Prevention |
Description: | The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem. |
Link to Additional Information: | |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Eric Gross
EUW9@cdc.gov Email:EUW9@cdc.gov |
DISPLAYING: Synopsis 9
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-CE15-1501 |
Funding Opportunity Title: | Prescription Drug Overdose Prevention for States |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 16 |
Assistance Listings: | 93.136 — Injury Prevention and Control Research and State and Community Based Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 9 |
Posted Date: | Mar 27, 2015 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | May 08, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
Archive Date: | Jun 07, 2015 |
Estimated Total Program Funding: | $55,600,000 |
Award Ceiling: | $1,000,000 |
Award Floor: | $750,000 |
Eligibility
Eligible Applicants: | State governments |
Additional Information on Eligibility: | Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost. Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding. Applicants must provide a Letter of Support (LOS) from: A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities. Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities. |
Additional Information
Agency Name: | Centers for Disease Control and Prevention |
Description: | The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem. |
Link to Additional Information: | |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Eric Gross
EUW9@cdc.gov Email:EUW9@cdc.gov |
DISPLAYING: Synopsis 8
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-CE15-1501 |
Funding Opportunity Title: | Prescription Drug Overdose Prevention for States |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 16 |
Assistance Listings: | 93.136 — Injury Prevention and Control Research and State and Community Based Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 8 |
Posted Date: | Mar 27, 2015 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | May 08, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
Archive Date: | Jun 07, 2015 |
Estimated Total Program Funding: | $55,600,000 |
Award Ceiling: | $1,000,000 |
Award Floor: | $750,000 |
Eligibility
Eligible Applicants: | State governments |
Additional Information on Eligibility: | Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost. Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding. Applicants must provide a Letter of Support (LOS) from: A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities. Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities. |
Additional Information
Agency Name: | Centers for Disease Control and Prevention |
Description: | The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem. |
Link to Additional Information: | |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Eric Gross
EUW9@cdc.gov Email:EUW9@cdc.gov |
DISPLAYING: Synopsis 7
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-CE15-1501 |
Funding Opportunity Title: | Prescription Drug Overdose Prevention for States |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 16 |
Assistance Listings: | 93.136 — Injury Prevention and Control Research and State and Community Based Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 7 |
Posted Date: | Mar 27, 2015 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | May 08, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
Archive Date: | Jun 07, 2015 |
Estimated Total Program Funding: | $55,600,000 |
Award Ceiling: | $1,000,000 |
Award Floor: | $750,000 |
Eligibility
Eligible Applicants: | State governments |
Additional Information on Eligibility: | Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost. Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding. Applicants must provide a Letter of Support (LOS) from: A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities. Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities. |
Additional Information
Agency Name: | Centers for Disease Control and Prevention |
Description: | The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem. |
Link to Additional Information: | |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Eric Gross
EUW9@cdc.gov Email:EUW9@cdc.gov |
DISPLAYING: Synopsis 6
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-CE15-1501 |
Funding Opportunity Title: | Prescription Drug Overdose Prevention for States |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 16 |
Assistance Listings: | 93.136 — Injury Prevention and Control Research and State and Community Based Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 6 |
Posted Date: | Mar 27, 2015 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | May 08, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
Archive Date: | Jun 07, 2015 |
Estimated Total Program Funding: | $55,600,000 |
Award Ceiling: | $1,000,000 |
Award Floor: | $750,000 |
Eligibility
Eligible Applicants: | State governments |
Additional Information on Eligibility: | Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost. Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding. Applicants must provide a Letter of Support (LOS) from: A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities. Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities. |
Additional Information
Agency Name: | Centers for Disease Control and Prevention |
Description: | The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem. |
Link to Additional Information: | |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Eric Gross
EUW9@cdc.gov Email:EUW9@cdc.gov |
DISPLAYING: Synopsis 5
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-CE15-1501 |
Funding Opportunity Title: | Prescription Drug Overdose Prevention for States |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 16 |
Assistance Listings: | 93.136 — Injury Prevention and Control Research and State and Community Based Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 5 |
Posted Date: | Mar 27, 2015 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | May 08, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
Archive Date: | Jun 07, 2015 |
Estimated Total Program Funding: | $55,600,000 |
Award Ceiling: | $1,000,000 |
Award Floor: | $750,000 |
Eligibility
Eligible Applicants: | State governments |
Additional Information on Eligibility: | Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost. Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding. Applicants must provide a Letter of Support (LOS) from: A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities. Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities. |
Additional Information
Agency Name: | Centers for Disease Control and Prevention |
Description: | The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem. |
Link to Additional Information: | |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Eric Gross
EUW9@cdc.gov Email:EUW9@cdc.gov |
DISPLAYING: Synopsis 4
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-CE15-1501 |
Funding Opportunity Title: | Prescription Drug Overdose Prevention for States |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 16 |
Assistance Listings: | 93.136 — Injury Prevention and Control Research and State and Community Based Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 4 |
Posted Date: | Mar 27, 2015 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | May 08, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
Archive Date: | Jun 07, 2015 |
Estimated Total Program Funding: | $55,600,000 |
Award Ceiling: | $1,000,000 |
Award Floor: | $750,000 |
Eligibility
Eligible Applicants: | State governments |
Additional Information on Eligibility: | Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost. Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding. Applicants must provide a Letter of Support (LOS) from: A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities. Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities. |
Additional Information
Agency Name: | Centers for Disease Control and Prevention |
Description: | The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem. |
Link to Additional Information: | |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Eric Gross
EUW9@cdc.gov Email:EUW9@cdc.gov |
DISPLAYING: Synopsis 3
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-CE15-1501 |
Funding Opportunity Title: | Prescription Drug Overdose Prevention for States |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 16 |
Assistance Listings: | 93.136 — Injury Prevention and Control Research and State and Community Based Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 3 |
Posted Date: | Mar 27, 2015 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | May 08, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
Archive Date: | Jun 07, 2015 |
Estimated Total Program Funding: | $55,600,000 |
Award Ceiling: | $1,000,000 |
Award Floor: | $750,000 |
Eligibility
Eligible Applicants: | State governments |
Additional Information on Eligibility: | Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost.Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding.Applicants must provide a Letter of Support (LOS) from:A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities.The state substance abuse services authority in their state. The LOS must show that the substance abuse authority supports the application and agrees to regular meetings to support and coordinate activities.The PDMP authority in their state showing the PDMP authority supports the application, agrees to quarterly meetings to support and coordinate activities, and how the PDMP authority will facilitate proposed activities for enhancing and maximizing the state’s PDMP.Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities.If the priority strategy of policy evaluation is chosen, applicants must provide a LOS from agencies that maintain access to relevant data the state will be using for evaluation. The LOS must indicate the agency’s support and agreement to share data for evaluation purposes. |
Additional Information
Agency Name: | Centers for Disease Control and Prevention |
Description: | The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem. |
Link to Additional Information: | |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Eric Gross
EUW9@cdc.gov Email:EUW9@cdc.gov |
DISPLAYING: Synopsis 2
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-CE15-1501 |
Funding Opportunity Title: | Prescription Drug Overdose Prevention for States |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 16 |
Assistance Listings: | 93.136 — Injury Prevention and Control Research and State and Community Based Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Mar 13, 2015 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | May 08, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
Archive Date: | Jun 07, 2015 |
Estimated Total Program Funding: | $55,600,000 |
Award Ceiling: | $1,000,000 |
Award Floor: | $750,000 |
Eligibility
Eligible Applicants: | State governments |
Additional Information on Eligibility: | Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost. Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding. Applicants must provide a Letter of Support (LOS) from: A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities. Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities. |
Additional Information
Agency Name: | Centers for Disease Control and Prevention |
Description: | The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem. |
Link to Additional Information: | |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Eric Gross
EUW9@cdc.gov Email:EUW9@cdc.gov |
DISPLAYING: Synopsis 1
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-CE15-1501 |
Funding Opportunity Title: | Prescription Drug Overdose Prevention for States |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 16 |
Assistance Listings: | 93.136 — Injury Prevention and Control Research and State and Community Based Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Mar 13, 2015 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | May 08, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
Archive Date: | Jun 07, 2015 |
Estimated Total Program Funding: | $55,600,000 |
Award Ceiling: | $1,000,000 |
Award Floor: | $750,000 |
Eligibility
Eligible Applicants: | State governments |
Additional Information on Eligibility: | Current Boost States: States funded under the Boost FOA (CDC-RFA-CE14-1404) are eligible to apply for this program. If a state currently receiving support under Prevention Boost receives funding under this FOA, it will no longer receive funding under Boost and will instead receive funding exclusively under this program. Prevention Boost states that do not apply or are not awarded funds under this program will continue their work under Boost. Because this funding requires activity to enhance state PDMPs, states where a PDMP is not authorized are not eligible to apply for this funding. Applicants must provide a Letter of Support (LOS) from: A state-level law enforcement authority in their state. The LOS must show that the law enforcement authority supports the application and agrees to regular meetings to support and coordinate activities. Applicants implementing insurer/health system interventions under Priority Strategy #2 must provide a LOS from the state authority managing the entity where the work is focused. For example, if a proposal is for creating an opioid management program for the state Medicaid program, show an LOS from the Medicaid authority. If improving an element of the Workers’ Compensation program, provide a LOS from the Workers’ Compensation authority. If the applicant is integrating and/or disseminating evidence-based opioid prescribing guidelines in partnership with a particular health system or insurance program, the applicant should include a LOS from that system or program. The LOS must demonstrate the authority’s support, agreement to quarterly meetings, and explanation of how the state authority will facilitate the proposed activities. |
Additional Information
Agency Name: | Centers for Disease Control and Prevention |
Description: | The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to also conduct policy evaluations or implement other prescribing innovations. These activities will impact the patient and provider behaviors driving the epidemic in the medium term and ultimately improve the health outcomes associated with this public health problem. |
Link to Additional Information: | |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Eric Gross
EUW9@cdc.gov Email:EUW9@cdc.gov |
Related Documents
Packages
Agency Contact Information: | Eric Gross EUW9@cdc.gov Email: EUW9@cdc.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
93.136 | CDC-RFA-CE15-1501 | Prescription Drug Overdose Prevention for States | PKG00215371 | Mar 06, 2015 | Jun 02, 2015 | View |